Abstrakt

Germany has introduced a national low-dose CT (LDCT) lung cancer screening program for adults aged 50 – 75 with substantial smoking history. The regulatory framework is defined by the national Lung Cancer Screening Regulation (Lungenkrebs-Früherkennungsverordnung) and Federal Joint Committee decisions. The program aims to reduce lung cancer mortality. Eligibility assessment is performed by trained physicians, while LDCT examinations are conducted in certified radiology centers following strict quality standards, including structured reporting based on the modified Lung-RADS system. Abnormal findings are investigated at a lung cancer center. Risks such as false positives, overdiagnosis, and low-dose radiation exposure are mitigated through standardized workflows, follow-up imaging, and digital decision support. Long-term effectiveness depends on sustained participation and close interdisciplinary collaboration.

Autoreninformation

Autoren

• T. Elgeti¹
• J. Vogel-Claussen¹
• R.-H. Hübner²

Abteilungen

• ¹ Klinik für Radiologie, Charité – Universitätsmedizin Berlin, Berlin,
• ² Klinik für Pneumologie, Beatmungsmedizin und Intensivmedizin mit dem Arbeitsbereich Schlafmedizin, Charité – Universitätsmedizin Berlin, Berlin

Adresse

Prof. Dr. med. Thomas Elgeti
Klinik für Radiologie
Charité – Universitätsmedizin Berlin
Hindenburgdamm 30
12203 Berlin
Email: [email protected]

Citation